Nanotechnology enabling the use of circulating tumor cells (CTCs) as reliable cancer biomarkers

Seungpyo Hong, Andrew Z. Wang

Research output: Contribution to journalEditorial

5 Citations (Scopus)
Original languageEnglish
Pages (from-to)1-2
Number of pages2
JournalAdvanced Drug Delivery Reviews
Volume125
DOIs
Publication statusPublished - 2018 Feb 1

Fingerprint

Circulating Neoplastic Cells
Nanotechnology
Tumor Biomarkers

All Science Journal Classification (ASJC) codes

  • Pharmaceutical Science

Cite this

@article{9a4e05b6cca54c7e89b0dbf2bd711b92,
title = "Nanotechnology enabling the use of circulating tumor cells (CTCs) as reliable cancer biomarkers",
author = "Seungpyo Hong and Wang, {Andrew Z.}",
year = "2018",
month = "2",
day = "1",
doi = "10.1016/j.addr.2018.04.014",
language = "English",
volume = "125",
pages = "1--2",
journal = "Advanced Drug Delivery Reviews",
issn = "0169-409X",
publisher = "Elsevier",

}

Nanotechnology enabling the use of circulating tumor cells (CTCs) as reliable cancer biomarkers. / Hong, Seungpyo; Wang, Andrew Z.

In: Advanced Drug Delivery Reviews, Vol. 125, 01.02.2018, p. 1-2.

Research output: Contribution to journalEditorial

TY - JOUR

T1 - Nanotechnology enabling the use of circulating tumor cells (CTCs) as reliable cancer biomarkers

AU - Hong, Seungpyo

AU - Wang, Andrew Z.

PY - 2018/2/1

Y1 - 2018/2/1

UR - http://www.scopus.com/inward/record.url?scp=85048508599&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85048508599&partnerID=8YFLogxK

U2 - 10.1016/j.addr.2018.04.014

DO - 10.1016/j.addr.2018.04.014

M3 - Editorial

C2 - 29880212

AN - SCOPUS:85048508599

VL - 125

SP - 1

EP - 2

JO - Advanced Drug Delivery Reviews

JF - Advanced Drug Delivery Reviews

SN - 0169-409X

ER -